Floatz logo

(+)-VINCRISTINE

Colon Cancer Liver Metastasis

Fujian Cancer HospitalSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Colon Cancer Liver Metastasis cohort.

Asset / SponsorPhaseRating
Raltitrexed
Fudan University
Phase 4BB
Ethiodized Oil
Giammaria Fiorentini
Phase 3BB
Theprubicin
Giammaria Fiorentini
Phase 3BB
Inno-206
M.D. Anderson Cancer Center
Phase 2B
DEXTROSE
Imunon
Phase 2CCC
ASN007
Asana BioSciences
Phase 1CC
Nkr-2 Cells
Celyad Oncology SA
Phase 1CC
Icosapent Ethyl
University of Leeds
D

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →